Spire Healthcare Group (LON:SPI) Trading Down 16.9% – Here’s Why

Spire Healthcare Group plc (LON:SPI)’s share price fell 16.9% during trading on Wednesday . The stock traded as low as GBX 185 and last traded at GBX 185.80. 8,659,000 shares traded hands during trading, an increase of 493% from the average session volume of 1,461,109 shares. The stock had previously closed at GBX 223.50.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. reduced their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of GBX 294.33.

Spire Healthcare Group Price Performance

The stock has a market capitalization of £747.61 million, a P/E ratio of 40.39, a PEG ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The firm has a fifty day moving average price of GBX 234.27 and a two-hundred day moving average price of GBX 222.02.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.